139 related articles for article (PubMed ID: 31605177)
21. Follicular and Diffuse Sclerosing Variant Papillary Thyroid Carcinomas as Independent Predictive Factors of Loco-Regional Recurrence: A Comparison Study Using Propensity Score Matching.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2016 Aug; 26(8):1077-84. PubMed ID: 27324748
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for local recurrence following lateral neck dissection for papillary thyroid carcinoma.
Raffaelli M; De Crea C; Sessa L; Tempera SE; Belluzzi A; Lombardi CP; Bellantone R
Endocrine; 2019 Feb; 63(2):310-315. PubMed ID: 30341706
[TBL] [Abstract][Full Text] [Related]
23. Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis.
Liu J; Zhang Z; Huang H; Xu S; Liu Y; Liu S; Wang X; Xu Z
Oral Oncol; 2019 Mar; 90():17-22. PubMed ID: 30846171
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
Zhao H; Huang T; Li H
Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological features of recurrent papillary thyroid cancer.
Zhu J; Wang X; Zhang X; Li P; Hou H
Diagn Pathol; 2015 Jul; 10():96. PubMed ID: 26168921
[TBL] [Abstract][Full Text] [Related]
26. KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease.
Viola D; Giani C; Mazzeo S; Ugolini C; Ciampi R; Molinaro E; Agate L; Borrelli N; Chella A; Fontanini G; Basolo F; Elisei R
J Clin Endocrinol Metab; 2017 Sep; 102(9):3091-3096. PubMed ID: 28911147
[TBL] [Abstract][Full Text] [Related]
27. Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.
Rubinstein JC; Dinauer C; Herrick-Reynolds K; Morotti R; Callender GG; Christison-Lagay ER
J Pediatr Surg; 2019 Jan; 54(1):129-132. PubMed ID: 30361076
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic characteristics and prognosis of diffuse sclerosing variant of papillary thyroid carcinoma in Japan: an 18-year experience at a single institution.
Fukushima M; Ito Y; Hirokawa M; Akasu H; Shimizu K; Miyauchi A
World J Surg; 2009 May; 33(5):958-62. PubMed ID: 19198928
[TBL] [Abstract][Full Text] [Related]
29. Diffuse sclerosing variant of papillary thyroid carcinoma: ultrasonographic and clinicopathological features in children/adolescents and adults.
Wang Q; Chang Q; Zhang R; Sun C; Li L; Wang S; Wang Q; Li Z; Niu L
Clin Radiol; 2022 May; 77(5):e356-e362. PubMed ID: 35197192
[TBL] [Abstract][Full Text] [Related]
30. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF
Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ
Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011
[TBL] [Abstract][Full Text] [Related]
31. Diffuse sclerosing variant is a major subtype of papillary thyroid carcinoma in the young.
Koo JS; Hong S; Park CS
Thyroid; 2009 Nov; 19(11):1225-31. PubMed ID: 19888860
[TBL] [Abstract][Full Text] [Related]
32. Multifocality related factors in papillary thyroid carcinoma.
Gur EO; Karaisli S; Haciyanli S; Kamer E; Genc H; Atahan K; Haciyanli M
Asian J Surg; 2019 Jan; 42(1):297-302. PubMed ID: 30585170
[TBL] [Abstract][Full Text] [Related]
33. Robotic-assisted modified radical neck dissection using a bilateral axillo-breast approach (robotic BABA MRND) for papillary thyroid carcinoma with lateral lymph node metastasis.
Yu HW; Chai YJ; Kim SJ; Choi JY; Lee KE
Surg Endosc; 2018 May; 32(5):2322-2327. PubMed ID: 29101559
[TBL] [Abstract][Full Text] [Related]
34. A Diagnostic Dilemma: Skip Metastasis in Papillary Thyroid Cancer.
Özden S; Çomçalı B; Ataş H; Er S; Tez M; Saylam B
Am Surg; 2020 Mar; 86(3):245-249. PubMed ID: 32223805
[TBL] [Abstract][Full Text] [Related]
35. Thyroglossal Duct Cyst Carcinomas: A Clinicopathologic Series of 22 Cases with Staging Recommendations.
Thompson LDR; Herrera HB; Lau SK
Head Neck Pathol; 2017 Jun; 11(2):175-185. PubMed ID: 27704385
[TBL] [Abstract][Full Text] [Related]
36. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.
Ryu YJ; Cho JS; Park MH; Yoon JH
BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes of central neck dissection for cN0 papillary thyroid carcinoma.
Giordano D; Frasoldati A; Gabrielli E; Pernice C; Zini M; Castellucci A; Piana S; Ciarrocchi A; Cavuto S; Barbieri V
Am J Otolaryngol; 2017; 38(5):576-581. PubMed ID: 28599790
[TBL] [Abstract][Full Text] [Related]
38. Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.
Nam SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Thyroid; 2018 Jan; 28(1):88-95. PubMed ID: 29117854
[TBL] [Abstract][Full Text] [Related]
39. Right posterior paratracheal lymph nodes metastasis is one of the predictive factors in right-sided papillary thyroid carcinoma.
Kim D; Kwon HK; Shin SC; Sung ES; Jeon YK; Kim BH; Kim IJ; Lee JC; Lee BJ
Surgery; 2019 Dec; 166(6):1154-1159. PubMed ID: 31444006
[TBL] [Abstract][Full Text] [Related]
40. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
